S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ABCL AbCellera Biologics Inc

3.43

-0.08 (-2.28%)

After Hours

Last Updated: 16:13:07

Delayed by 15 minutes

AbCellera Biologics Q3 2021 Earnings Preview

To read the full story on Seeking Alpha, click here.

AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more AbCellera Biologics Charts.

AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more AbCellera Biologics Charts.

AbCellera Biologics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 3 June 2024 (1 week ago) • Edgar (US Regulatory)

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
Tuesday 28 May 2024 (2 weeks ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 7 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 May 2024 (1 month ago) • Edgar (US Regulatory)

AbCellera Reports Q1 2024 Business Results
Tuesday 7 May 2024 (1 month ago) • Business Wire

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
Wednesday 1 May 2024 (1 month ago) • Business Wire

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
Monday 8 April 2024 (2 months ago) • Business Wire

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
Wednesday 3 April 2024 (2 months ago) • Business Wire

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
Tuesday 19 March 2024 (3 months ago) • Business Wire

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Monday 11 March 2024 (3 months ago) • Business Wire

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
Tuesday 5 March 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (3 months ago) • Edgar (US Regulatory)

More AbCellera Biologics Inc News Articles

NLBNPIT20TS3 20351221 10...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions